click below
click below
Normal Size Small Size show me how
Oncology
Gynecologic Tumors
| Term | Definition |
|---|---|
| Gynecologic cancer that is most prevalent in younger women | Cervical cancer (Mosbys pg. 173) |
| Rare gynecologic cancers that appear mostly in older women | Vaginal and vulvar cancer (Mosbys pg. 175) |
| Fifth leading cause of death in women following lung, breast, colon, and pancreatic cancer | Ovarian cancer (Mosbys pg. 175) |
| Pattern of lymphatic spread in vulvar cancer | Superficial inguinal nodes first, followed by deep femoral nodes, then pelvic nodes (Mosbys pg. 175) |
| Most common location for vaginal cancer to arise | Posterior upper third of vagina (Mosbys pg. 176) |
| Pattern of lymphatic spread for cervical cancer | Parametrial nodes followed by pelvic, common iliac, periaortic, and supraclavicular spread (Mosbys pg. 177) |
| Treatment of choice for cancer of vagina | Radiation therapy/brachytherapy- Cs 137 or Ir 192 (Mosbys pg. 177) |
| Most common histology of vaginal cancer | Squamous cell (Mosbys pg. 177) |
| Most common histology of endometrial cancer | Adenocarcinoma (Mosbys pg. 179) |
| Treatment for medically inoperable cervical cancer patients | Tandem and ovoids with 45 to 55 Gy to point (Mosbys pg. 178) |
| Intrauterine tandem | Small, hollow, curved cylinder that fits through cervical os into uterus- Point A (Mosbys pg. 178) |
| Vaginal colpostats | Two golf club shaped, hollow tubes placed laterally to tandem into vaginal fornices- Point B (Mosbys pg. 178) |
| Point A | Prescription point defined as 2 cm superior to cervical os and 2 cm lateral to endocervical canal (Mosbys pg. 179) |
| Point B | Prescription point defined as 2 cm superior to cervical os and 5 cm lateral to endocervical canal/3 cm lateral to Point A (Mosbys pg. 179) |
| Pattern of lymphatic spread for endometrial cancer | Initially to internal and external iliac (Mosbys pg. 179) |
| Tumor involves one or both ovaries with pelvic extension and/or implants | Stage II Ovarian Cancer (Mosbys pg. 180) |
| Reason for effectiveness of brachytherapy with uterine and cervical cancers | Uterus and cervix tolerate extremely high doses of radiation (W/L pg. 805) |
| Most radiosensitive gynecologic structure | Ovary (W/L pg. 805) |
| Women who take this drug are at an increased risk of endometrial cancer | Tamoxifen (W/L pg. 815) |
| Most prevalent gynecologic cancer | Endometrial cancer (W/L pg. 820) |